Zevra Therapeutics Inc. (ZVRA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zevra Therapeutics Inc.

    NASDAQ: ZVRA · Real-Time Price · USD
    9.75
    0.44 (4.73%)
    At close: Oct 03, 2025, 3:59 PM
    9.75
    0.00%
    After-hours: Oct 03, 2025, 06:07 PM EDT

    Zevra Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 23.61M 27.46M 10.16M 28.65M
    Cost of Revenue
    		 7.42M 2.94M 222K 2.06M
    Gross Profit
    		 16.2M 24.52M 9.94M 26.59M
    Operating Income
    		 -87M -49.6M -42.56M 7.73M
    Interest Income
    		 2.17M 4.54M 1.51M 261K
    Pretax Income
    		 -90.14M -46.05M -26.8M -8.52M
    Net Income
    		 -105.51M -46.05M -26.77M -8.55M
    Selling & General & Admin
    		 54.87M 35.09M 15.04M 8.7M
    Research & Development
    		 42.09M 39.81M 19.8M 10.16M
    Other Expenses
    		 6.24M -775K 17.66M n/a
    Operating Expenses
    		 103.2M 74.12M 52.5M 18.86M
    Interest Expense
    		 7.35M 1.5M 335K 376K
    Selling & Marketing Expenses
    		 n/a n/a -305K n/a
    Cost & Expenses
    		 110.61M 77.06M 52.73M 20.92M
    Income Tax Expense
    		 15.37M n/a -33K 34K
    Shares Outstanding (Basic)
    		 46.25M 35.45M 34.49M 29.77M
    Shares Outstanding (Diluted)
    		 46.25M 35.45M 34.49M 29.77M
    EPS (Basic)
    		 -2.28 -1.3 -0.78 -2.11
    EPS (Diluted)
    		 -2.28 -1.3 -0.78 -2.11
    EBITDA
    		 -76.4M -43.54M -25.53M -7.89M
    EBIT
    		 -82.79M -44.55M -26.47M -8.14M
    Depreciation & Amortization
    		 6.39M 1.01M 944K 257K

    Add to Watchlist